Impaired effect of endothelin-1 on coronary artery stiffness in type 2 diabetes

International Journal of Cardiology

Volumn 112, Issue 2, 2006, Pages 207-212

  Kyriakides, Zenon S ^a   Kremastinos, Dimitrios Th ^a   Raptis, Athanasios E ^a   Johnston, Neil ^b   Raptis, Sotirios A ^a   Webb, David J ^b   Kyrzopoulos, Stamatis ^c   Sbarouni, Eftichia ^c  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Artery elasticity; Catheterization; Endothelin; Type 2 diabetes mellitus

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTICLE; CALCULATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART RATE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE PRESSURE; HUMAN; INTRAVASCULAR ULTRASOUND; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PULSE PRESSURE; SAMPLE SIZE;

AGED; ALDOSTERONE; COMPLIANCE; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; ENDOTHELIN-1; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PERICARDIUM; PROSPECTIVE STUDIES; PULSATILE FLOW; RECEPTORS, ENDOTHELIN; RENIN; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33748606113     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.09.018     Document Type: Article

References (18)

1. Kyriakides Z.S., Kremastinos D., Bofilis E., Tousoulis D., Antoniadis A., and Webb D.J. Endogenous endothelin type A receptor stimulation in patients undergoing coronary arteriography. Heart 84 (2000) 176-182
2. Chakravarthy U., McGinty A., McKillop J., Anderson P., Archer D.B., and Trimble E.R. Altered endothelin-1 induced contraction and second messenger generation in bovine retinal microvascular pericytes cultured in high glucose medium. Diabetologia 37 (1994) 36-42
3. Hodgson W.C., and King R.G. Effects of glucose, insulin or aldose reductase inhibition on responses to endothelin-1 of aortic rings from streptozotocin-induced diabetic rats. Br J Pharmacol 106 (1992) 644-649
4. Nugent A.G., McGurk C., Hayes J.R., and Johnston G.D. Impaired vasoconstriction to endothelin 1 in patients with NIDDM. Diabetes 45 (1996) 105-107
5. McAuley D.F., McGurk C., Nugent A.G., Hanratty C., Hayes J.R., and Johnston G.D. Vasoconstriction to endothelin-1 is blunted in non-insulin-dependent diabetes: a dose-response study. J Cardiovasc Pharmacol 36 (2000) 203-208
6. Jeremias A., Spies C., Herity N.A., et al. Coronary artery compliance and adaptive vessel remodeling in patients with stable and unstable coronary artery disease. Heart 84 (2000) 314-319
7. Jeremias A., Spies C., Herity N.A., et al. Coronary artery distensibility and compensatory vessel enlargement-a novel parameter influencing vascular remodeling?. Basic Res Cardiol 96 (2001) 506-512
8. Vavuranakis M., Stefanadis C., Triandafyllidi E., Toutouzas K., and Toutouzas P. Coronary artery distensibility in diabetic patients with simultaneous measurements of luminal area and intracoronary pressure. Evidence of impaired reactivity to nitroglycerin. J Am Coll Cardiol 34 (1999) 1075-1081
9. Kyriakides Z.S., Kremastinos D.Th., Kolokathis F., Kostopoulou A., Georgiadis M., and Webb D.J. Acute endothelin A receptor antagonism improves coronary artery compliance in coronary artery disease patients. Clin Sci 103 (2002) 179S-183S
10. Haynes W.G., and Webb D.J. The endothelin family of peptides: local hormones with diverse roles in health and disease?. Clin Sci 84 (1993) 485-500
11. Ihara M., Noguchi K., Saeki T., et al. Biological profiles of highly potent endothelin antagonists selective for the endothelin A receptor. Life Sci 50 (1992) 247-255
12. Rolinski B., Sadri I., Bogner J., and Goebel F.D. Determination of endothelin-1 immunoreactivity in plasma, cerebrospinal fluid and urine. Res Exp Med (Berl) 194 (1994) 9-24
13. Marano G., Grigioni M., Palazzesi S., and Ferrari A.U. Endothelin and mechanical properties of the carotid artery in Wistar-Kyoto and spontaneously hypertensive rats. Cardiovasc Res 41 (1999) 701-707
14. Cardillo C., Campia U., Bryant M.B., and Panza J.A. Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation 106 (2002) 1783-1787
15. Halkin A., Benjamin N., Doktor H.S., Todd S.D., Viberti G., and Ritter J.M. Vascular responsiveness and cation exchange in insulin-dependent diabetes. Clin Sci 81 (1994) 223-232
16. Vora J.P., Dolben J., Williams J.D., Peters J.R., and Owens D.R. Impact of initial treatment on renal function in newly-diagnosed Type II (non-insulin-dependent) diabetes mellitus. Diabetologia 36 (1993) 734-740
17. McAuley D.F., Nugent A.G., McGurk C., Maguire S., Hayes J.R., and Johnston G.D. Vasoconstriction to endogenous endothelin-1 is impaired in patients with type II diabetes mellitus. Clin Sci 99 (2000) 175-179
18. Christlieb A.R., Janka H.U., Kraus B., et al. Vascular reactivity to angiotensin II and nor epinephrine in diabetic subjects. Diabetes 25 (1976) 268-274